Science

Oscar Tahuahua/X

Aug 12, 2025, 17:40

Oscar Tahuahua: Triple M from ICIs

Oscar Tahuahua, Medical Oncology Fellow at the National Cancer Institute of Mexico, shared a post on X about a paper by published in Cancer Treatment Reviews:

“Triple M (myasthenia+myositis+myocarditis) from ICIs – 38% mortality (50% resp. failure, 41% tox)

ICI neurotoxicity: 0.24% in trials, 2–4% of irAEs; 40–60% lasting deficits, 6–17% mortality

ACT FAST: steroids + intensive cardio-resp. monitoring.”

Title: Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis

Authors: Dorte Lisbet Nielsen, Carsten Bogh Juhl, Inna Markovna Chen, Yinghong Wang, Ole Haagen Nielsen, Bianca Denise Santomasso.

You can read the Full Article on Cancer Treatment Reviews.

Oscar Tahuahua: Triple M from ICIs

More posts featuring Oscar Tahuahua.

Bianca Denise Santomasso cancer Carsten Bogh Juhl Dorte Lisbet Nielsen Inna Markovna Chen Ole Haagen Nielsen OncoDaily Oncology Oscar Tahuahua Yinghong Wang

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Ramy Sedhom: Palliative Care Isn’t Just about When. It’s about Who, What, and How

Miriam Mutebi: One Small Grant, One Big Difference

Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders